EVO-NANO Evolvable platform for programmable nanoparticle-based cancer therapies
Dra. Isabel Rodríguez
-
Funding :
European Commission H2020-FETOPEN-2016-2017 no 800983
-
Duration: 2018 - 2022
EVO-NANO aims to create an integrated cross-disciplinary platform for the artificial evolution and assessment of nanoparticle-based drug delivery systems.
http://evonano.eu/